Scientists develop a potential antibiotic from Komodo dragon blood
Komodo dragon blood may hold the key to tackling the “looming crisis” of antimicrobial resistance, according to scientists behind a potential new antibiotic, DRGN-6.
The synthetic molecule, developed by experts at George Mason University in the United States, was created by combining two genes found in Komodo dragon blood – an endangered species found on five Indonesian islands.
In preclinical tests DRGN-6 killed carbapenem-resistant Klebsiella pneumoniae, a highly drug resistant bacteria which causes a particularly aggressive form of pneumonia.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!